What's new? Log in Free sign up

Puma Biotechnology (PBYI) News and press releases

Company Profile

News

From Benzinga Pro

HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

News, Price Target, Reiteration, Analyst Ratings

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Puma Biotechnology Sees Q3 Revenue $50M-$53M Vs $57.85M Est.; FY24 Revenue $183M-$190M Vs $217.63M Est.

Third Quarter and Full Year 2024 Financial Outlook Third Quarter 2024Full Year 2024Net Product Revenue$50 -53 million$183 - $190 millionRoyalty Revenue$20 - $22 million$30 - $33 millionLicense Revenue$0 million$1 -

Puma Biotechnology Q2 2024 Adj. EPS $(0.05) Beats $(0.13) Estimate, Sales $47.100M Beat $44.700M Estimate

Earnings, Earnings Beats, News

Puma Biotechnology (NASDAQ:PBYI) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.13) by 61.54 percent. The company reported quarterly sales of $47.100 million which beat

Where Puma Biotechnology Stands With Analysts

Analyst Ratings

HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

News, Price Target, Reiteration, Analyst Ratings

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Press releases

From Benzinga Pro

Puma Biotechnology to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder, will provide an overview of the Company at 3:00 p.m. EDT on

The Future of Medicine: Key Biotech Stocks to Watch (OSTX, CRBP, PBYI, ATNM)

News, Press Releases

In today's rapidly advancing healthcare landscape, biotech companies are playing a crucial role in addressing some of the most challenging medical conditions. With a focus on innovation and precision, these companies are

The Future of Medicine: Key Biotech Stocks to Watch

Naples, Florida--News Direct--In today's rapidly advancing healthcare landscape, biotech companies are playing a crucial role in addressing some of the most challenging medical conditions. With a focus on innovation

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced that on August 5, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, will host a conference call at 1:30 p.m. PDT/4:30 p.m. EDT on Thursday, August 1, 2024, following the release of its second quarter 2024 financial

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Puma Biotechnology, Inc. (NASDAQ:PBYI), a biopharmaceutical company, announced that on July 1, 2024, the Compensation Committee of Puma's Board of Directors approved the grant of an inducement restricted stock unit

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.